Medicine as per BNF category |
Arrangement for supply or administration |
Legal |
Version of page |
Scottish National Midwifery Formulary |
|
|
V3 |
|
|
Antacids |
||||
ME |
GSL |
V3 |
In Patient admission for duration. Out Patient 1 pack on each occasion. Dose 10 to 20ml 3 to 4 |
|
ME |
GSL |
V2 |
In Patient admission for duration. Out Patient 1 pack on each occasion. Dose 10 to 20ml 3 to 4 |
|
ME |
GSL |
V2 |
In Patient admission for duration. Dose 20ml PRN oral, for wind up to 4 times daily. |
|
Laxatives |
||||
ME |
GSL |
V3 |
In Patient admission for duration. Out Patient 1 pack on each occasion. Dose 1 sachet BD oral. |
|
ME |
P |
V2 |
In Patient admission for duration. Out Patient 1 pack on each occasion. Dose up to 15ml BD oral. |
|
ME |
GSL |
V3 |
In Patient max 7 days. Out Patient 1 pack on each occasion. Dose up to 2 tab or 10ml OD oral. |
|
ME |
GSL |
V2 |
In Patient or Out Patient. 1 Dose daily PR for maximum of 2 days. |
|
ME |
P |
V2 |
In Patient or Out Patient. 1 Dose daily PR for maximum of 2 days. |
|
ME |
P |
V2 |
In Patient or Out Patient. 1 Dose only PR. |
|
Preparations for haemorrhoids |
||||
ME |
GSL |
V3 |
In Patient or Out Patient. One pack of cream and suppositories may be supplied on each occasion. |
|
ME |
P |
V3 |
In Patient or Out Patient. One pack once only on one occasion. Use topically for maximum of 7 |
|
ME |
P |
V2 |
In Patient or Out Patient. One pack once only on one occasion. Use PR for maximum of 7 days in |
|
ME |
POM |
V3 |
In Patient or Out Patient. One pack once only on one occasion. Use topically for maximum of 3 weeks in accordance with manufacturer’s |
Midwifery Formulary for Mothers
What's new / Latest updates
29/03/2023 Amendment to guidance on Lidocaine hydrochloride 1% inj. (for perineum) to clarify administration and dosage when calculating by weight of patient.
Medicine as per BNF category |
Arrangement for supply or administration |
Legal |
Version of page |
Scottish National Midwifery Formulary |
|
|
V2 |
|
|
ME |
POM |
V2 |
In Patient or Out Patient. 0.5ml IM repeated after 5 min. if required. |
Medicine as per BNF category |
Arrangement for supply or administration |
Legal |
Version of page |
Scottish National Midwifery Formulary |
|
|
V3 |
|
|
Drugs used in nausea |
||||
ME |
POM |
V3 |
In Patient. Maximum 2 doses 8 hours apart. For antenatal nausea and vomiting in hyperemesis gravidarum as per local guideline or for control of nausea in conjuction with opiate analgesia in labour. Dose 12.5mg deep IM inj. Repeat once after 8 hours if required. |
|
ME |
POM |
V3 |
In Patient. Maximum 2 doses 8 hours apart. For control of nausea in conjunction with opiate analgesia in labour. Dose 50mg deep IM inj. Repeat once after 8 hours if required. |
|
Analgesics |
||||
ME |
GSL / P / POM |
V3 |
In Patient max. 4 days. Out Patient 1 pack of tablets on each occasion. Dose 1-2 suppositories of 500mg PR or 1 – 2 tablets every 4 to 6hrs oral as required. Lower dose in women ≤ 50kg. Max. 4 doses in 24 hours. |
|
ME |
GSL / P / POM |
V3 |
Practice Alert – postnatal use only. |
|
ME |
POM |
V3 |
Practice Alert – postnatal use only. |
|
ME |
P |
V3 |
Inhalation analgesia during labour in accordance with local guidelines. Max. duration 24 hours. |
|
ME |
POM (CD) |
V3 |
In Patient. To be used in accordance with relevant local home birth or Labour Ward Guideline. |
|
ME |
POM (CD) |
V3 |
In Patient. To be used in accordance with relevant local home birth or Labour Ward Guideline. |
|
PGD |
POM (CD) |
V3 |
Use in accordance with local guidelines. |
|
ME |
POM (CD) |
V3 |
In Pt. To be used in accordance with relevant local home birth or Labour Ward Guideline. Dose 5-10mg IM. A further 2 doses may be given at 4 hour intervals if necessary. Maximum of 3 doses to be given prior to referral to medical staff. |
|
Opioid Antagonists |
||||
ME |
POM |
V3 |
In Patient. 400microgram dose IM and can be repeated within 1-2hours depending on the type, dose and frequency of opioids. Observe closely as repeated doses may be required within 1-2 hours as the duration of action of opioids is longer than naloxone. |
Medicine as per BNF category |
Arrangement for supply or administration |
Legal |
Version of page |
Scottish National Midwifery Formulary |
V2 |
|
|||
Emergency administration |
POM |
V2 |
In Patient. One dose only. Dose 1mg IM inj. |
Medicine as per BNF category |
Arrangement for supply or administration |
Legal |
Version of page |
Scottish National Midwifery Formulary |
V3 |
|
|||
PGD |
POM |
V3 |
See local guideline for use. Insert one dose (10mg) into the posterior fornix. One dose only, to be removed after 24 hours if not sooner – see PGD and SPC for further information if required. |
|
PGD |
POM |
V1 |
See local guideline for use. Insert one dose (1mg or 2mg) in accordance with guideline high into the posterior fornix. Followed by a second dose (1mg or 2mg) if required, after 6 hours in accordance with guideline; max 3 or 4mg per course. |
|
PGD |
POM |
V3 |
See local guideline for use. Insert 1 tablet |
|
ME |
POM |
V3 |
See local guideline for use. 250 microgram (1ml) |
|
ME |
POM |
V3 |
Practice alert - Inadvertent administration to the newborn infant has proved fatal. |
|
ME |
POM |
V3 |
In Patient Oxytocin injection or infusion to be used in accordance with the applicable home birth or labour ward guidelines for management of third stage, induction or augmentation of
|
|
ME |
POM |
V3 |
||
Oxytocin (Syntocinon®) |
ME |
POM |
V2 |
|
ME |
POM |
V3 |
See local postpartum haemorrhage guideline for use. 500microgram (1ml) by IV or IM injection |
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V3 | ||||
Omeprazole 20mg capsule | PGD (GGC version) | POM | V1 | See local guidelines for use as prophylaxis against acid aspiration (Mendelson’s Syndrome). |
Ranitidine Injection | PGD * GGC | POM | V7 | Not sent out by editorial board * local GGC PGD – see end |
Sodium Citrate | PGD * GGC | POM | V7 | Not sent out by editorial board * local GGC PGD – see end |
*Available on request from Patient.GroupDirections@ggc.scot.nhs.uk Source acknowledged from NHS Greater Glasgow and Clyde by editorial board.
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V2 | ||||
ME | GSL / P | V2 | In Patient or Out Patient. One pack of cream may be supplied on each occasion. Use in accordance with manufacturer’s instructions. May be | |
ME | GSL / P | V2 | In Patient or Out Patient. One original pack of pessaries may be supplied on each occasion. Use in accordance with manufacturer’s instructions. May be repeated once without referral to a | |
ME | POM | V2 | In Patient or Out Patient. One pack of cream may be supplied on each occasion. Use in accordance with manufacturer’s instructions. May be |
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V3 | ||||
ME | GSL | V2 | Out Patient. One tablet daily until 12 weeks of pregnancy in women at low risk of conceiving a child with neural tube defect. One original pack of tablets on each occasion. | |
PGD | POM | V3 | In Patient or Out Patient. One tablet daily until 12 weeks of pregnancy in women at increased risk of conceiving a child with neural tube defect (women with established folate deficiency or sickle-cell disease should continue taking their normal dose of folic acid 5mg daily (or to increase the dose to 5mg daily) and continue this throughout pregnancy). | |
ME | P | V2 | In Patient admission duration. Out Patient 1 pack on each occasion. For women during 2nd or | |
ME | P | V3 | GGC Guideline – note variation from National Midwifery Formulary Monograph. See local guideline. | |
ME | P | V2 | In Patient admission duration. Out Patient 1 pack on each occasion. Iron deficiency anaemia in accordance with local guidelines. | |
ME | P | V3 | In Patient admission duration. Out Patient 1 pack on each occasion. Iron deficiency anaemia in | |
ME | P | V3 | In Patient admission. Out Patient 1 pack on each occasion. |
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V3 | ||||
ME | POM | V2 | Antenatal or postnatal women requiring resuscitation with IV fluids including hypotension, | |
ME | POM | V3 | Antenatal or postnatal women requiring | |
PGD | POM | V1 | Antenatal or postnatal women requiring resuscitation with IV fluids including hypotension, | |
ME | POM | V3 | IV flush 5ml to 10ml Antenatal or postnatal women requiring resuscitation with IV fluids including hypotension, haemorrhage. |
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V3 | ||||
ME | P | V2 | In Patient or Out Patient. Use topically in accordance with manufacturer’s instructions on | |
ME | P | V2 | In Patient or Out Patient. Use topically in accordance with manufacturer’s instructions on | |
ME | POM | V2 | *Consider patient weight when administering 1% lidocaine; if any queries contact anaesthetist. Women requiring an episiotomy or requiring perineal suturing after delivery: | |
PGD | POM | V2 | Up to 0.5ml infiltrated at site of cannulation. Maximum of 3 doses on each occasion. | |
ME | P | V2 | Women requiring urinary catheter insertion. 6ml to 11ml instilled into urethra and wait 3 to 5 min. before catheterisation. May be used prior to each catheterisation. |
Medicine as per BNF category | Arrangement for supply or administration | Legal | Version of page | Scottish National Midwifery Formulary |
V2 | ||||
Anti D Immunoglobulin | ME | POM | V3 | See local guideline for use. Dose as instructed by BTS. IM injection within 72 hours of delivery but check results of Kleihauer elution test. Blood |
AntiD Immunoglobulin- | ME | POM | V3 | See local guideline for use. 1500 international units at 28 to 30 weeks of pregnancy by IM |
Anti D Immunoglobulin | ME | POM | V3 | See local guideline for use. 500 international units at both 28 and 34 weeks of pregnancy by |
Anti D Immunoglobulin | ME | POM | V3 | See local guideline for use. A test for the size of the fetal maternal haemorrhage should be performed when anti-D is given after 20 weeks and additional doses of anti-D should be administered. BTS will advise on dosage. To be given as soon as possible and within 72 hours. Seek further advice if more time has elapsed. Maximum of 1 dose per incident or as advised by BTS. |
Anti-D | ME | POM | V3 | See local guideline for use. BTS will advise on dosage. To be given as soon as possible and within 72 hours. Seek further advice if more time has elapsed. Maximum of 1 dose per incident or as advised by BTS. |
Below is the additional list of locally agreed PGD’S for use by midwives in GG&C.
*Available on request from Patient.GroupDirections@ggc.scot.nhs.uk Source acknowledged from NHS Greater Glasgow and Clyde by editorial board.
GGC PGD Medicine | Arrangement for supply or administration | Legal Status | Version of page | Greater Glasgow and Clyde Midwifery Formulary local arrangements |
---|---|---|---|---|
Antibiotics | ||||
Benzylpenicillin 600mg inj. GBS | PGD * | POM | V7 | See Local Obstetric Group B Strep guideline and Neonatal GBS Infection guideline. Intrapartum Antibiotic Prophylaxis. During labour: Loading dose – Benzylpenicillin 3g IV infusion , over 30 minutes as soon as possible after the onset of labour and maintenance dose 1.8g every 4 hours until delivery. If patient allergic to penicillin, Teicoplanin to be administered, please refer to Teicoplanin PGD. Note: Refer to medical staff for additional antibiotic cover if GBS with suspected chorioamnionitis or sustained pyrexia. |
Teicoplanin | PGD * | POM | V1 | Under development at present. |
Calcium Gluconate 10% inj. (1g/10mls) | PGD * | POM | V6 | Community Midwifery Unit (CMU) Midwives Emergency treatment for hypermagnesaemia following magnesium sulphate treatment for eclampsia and severe eclampsia in pregnant women. Inclusion criteria: Pregnant women undergoing emergency magnesium sulphate treatment for eclampsia who are experiencing loss of reflexes and respiratory depression. Pregnant women: 1gram in 10mls IV slowly over 10mins by slow IV push. One dose only. Contact medical staff at CLU for advice immediately. |
Etonogestrel Single Rod Contraceptive Implant | PGD * | POM | V9 | Long acting reversible sub dermal contraceptive implant for women aged 13 years and above requesting contraceptive implant. See PGD on information for use by midwives. |
Influenza vaccine (seasonal). Inactivated TETRA and TRIVALENT 2019-2020 | PGD * | POM | V19 | PGD – for individuals for whom live attenuated intranasal vaccine (LAIV) is contraindicated e.g. pregnancy or unacceptable due to porcine gelatin content. See PGD for information on use by midwives. |
Labetalol 200mg tablets | PGD * | POM | V6 | Community Midwifery Unit (CMU) Midwives in accordance with CMU Protocol – Control of Severe hypertension. Contact Consultant Obstetrician at CLU for immediate advice prior to administration. Pregnant women: 200mg as a single dose oral prior to transfer to CLU. Note exclusion criteria, if applicable Nifedipine may be administered as an alternative please refer to Nifedipine 10mgs PGD. |
Magnesium sulphate IM | PGD * Magnesium Sulphate IM | POM | V4 | Community Midwifery Unit (CMU) Midwives in accordance with CMU Protocol – Eclampsia and Severe Pre-eclampsia. Contact Consultant Obstetrician at CLU for immediate advice prior to administration. Emergency treatment for eclampsia and severe pre-eclampsia to prevent recurrent seizures prior/during transfer to Consultant Led Unit (CLU). Dose: Magnesium Sulphate 10g IM divided into 2 separate site injections (5g + 5g). One dose only. Note warnings and monitoring advice. |
Magnesium Sulphate Infusion | PGD * | POM | V6 | Community Midwifery Unit (CMU) Midwives in accordance with CMU Protocol – Eclampsia and Severe Pre-eclampsia. Contact Consultant Obstetrician at CLU for immediate advice prior to administration. Pregnant women: Loading Dose: 4g/8ml given IV diluted in 12ml of 0.9% sodium chloride IV solution over 5 mins. By slow manual infusion. Maintenance dose: By syringe driver at a rate of 1g/hour continuous intravenous infusion. i.e. 5mls /hour. Draw up 20mls (10g) of Magnesium Sulphate 50% inj. Then add to 30mls of 0.9% Sodium Chloride inj. Note exclusion criteria and cautions. |
Medroxyprogesterone injectable contraception | PGD * | POM | V7 | PGD for contraception - Any woman aged 13 years or more to 50 years with no known risk factors or contraindications, who has been informed of the mode of action, method of administration , advantages, disadvantages and potential side effects in particular the effects on bone mineral density. See PGD for information on use by midwives. |
Misoprostol | PGD * | POM | V4 | See GGC Obstetric Guideline – Post Partum Haemorrhage (PPH) Management. Emergency treatment of women having a PPH: Misoprostol 200microgram tablets (oral) give 800microgram (4 tablets) rectal – preferred route, for one dose only as per guideline and CLU advice. Note exclusion criteria. |
Nifedipine | PGD * Nifedipine 10mgs capsule | POM | V4 | Community Midwifery Unit (CMU) Midwives in accordance with CMU Protocol – Control of Severe hypertension. Contact Consultant Obstetrician at CLU for immediate advice prior to administration. Pregnant women: 10mg nifedipine capsule as a single dose oral prior to transfer to CLU. Note exclusion criteria and warnings. |
Omeprazole 20mg capsule | PGD (GGC version) | POM | V1 | See local guidelines for use as prophylaxis against acid aspiration (Mendelson’s Syndrome). Elective Caesarean Section (CS) 20mg oral to be given the night before and the morning of the elective CS operation. OP pack of 2 doses. Labour see guideline for inclusion criteria- for “high risk” patients. 20mg every 12 hours until delivery, review after 24 hours. Maximum 3 doses. |
Pertussis vaccine | PGD * | POM | V8 | 1 dose for immunisation of pregnant and newly delivered women against pertussis (whooping cough) in line with the latest CMO letter. In accordance with PGD. |
Progesterone only oral contraception | PGD * | POM | V8 | PGD for contraception - Any woman aged 13 years or more to 50 years with no known risk factors or contraindications, who has been informed of the mode of action, method of administration , advantages, disadvantages and potential side effects. See PGD for information on use by midwives. |
Ranitidine 50mg/2ml inj. | PGD * | POM | V7 | See local guideline. 50mg as a single dose IM or IV for all women in labour, or of greater than 20 weeks gestation or less than 3 days postpartum who require emergency general anaesthesia. |
Sodium Citrate 0.3Molar Oral Solution in 30ml | PGD * | POM | V7 | To increase the pH of gastric contents before general anaesthesia. See local guideline. 30ml as a single dose oral for all women in labour, or of greater than 20 weeks gestation or less than 3 days postpartum who require emergency general anaesthesia. |